作者
Zakaria Guetarni,R Bernard,Grégoire Boulouis,Marc‐Antoine Labeyrie,Alessandra Biondi,Stéphane Velasco,Guillaume Saliou,Bruno Bartolini,Benjamin Daumas-Duport,Romain Bourcier,Kévin Janot,Denis Herbreteau,Caterina Michelozzi,Kévin Premat,Hocine Redjem,Simon Escalard,Nicolas Bricout,Pierre Thouant,Charles Artéaga,Laurent Pierot,F. Tahon,K. Boubagra,Léon Ikka,Emmanuel Chabert,Stéphanie Lenck,Alexis Guédon,Arturo Consoli,Suzana Saleme,Géraud Forestier,Federico Di Maria,Jean–Christophe Ferré,René Anxionnat,François Eugène,Basile Kerleroux,Cyril Dargazanli,Nader Sourour,Frédéric Clarençon,Eimad Shotar
摘要
Non-ischemic cerebral enhancing (NICE) lesions following aneurysm endovascular therapy are exceptionally rare, with unknown longitudinal evolution.To evaluate the radiological behavior of individual NICE lesions over time.Patients included in a retrospective national multicentric inception cohort were analyzed. NICE lesions were defined, using MRI, as delayed onset punctate, nodular, or annular foci enhancements with peri-lesion edema, distributed in the vascular territory of the aneurysm treatment, with no other confounding disease. Lesion burden and the longitudinal behavior of individual lesions were assessed.Twenty-two patients were included, with a median initial lesion burden of 36 (IQR 17-54) on the first MRI scan. Of the 22 patients with at least one follow-up MRI scan, 16 (73%) had new lesions occurring mainly within the first 200 weeks after the date of the procedure. The median number of new lesions per MRI was 6 (IQR 2-16). Among the same 22 patients, 7 (32%) had recurrent lesions. The median persistent enhancement of a NICE lesion was 13 weeks (IQR 6-30). No factor was predictive of early regression of enhancement activity with lesion regression kinetics mainly being patient-dependent.The behavior of individual NICE lesions was found to be highly variable with an overall patient-dependent regression velocity.